domingo, 11 de diciembre de 2016

Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry. - PubMed - NCBI

Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry. - PubMed - NCBI
 2016 Nov 29. pii: S1885-5857(16)30330-9. doi: 10.1016/j.rec.2016.10.010. [Epub ahead of print]

Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.

[Article in English, Spanish]

Abstract

INTRODUCTION AND OBJECTIVES:

Little is known about the characteristics of persons with familial hypercholesterolemia (FH) younger than 18 years, the lipid-lowering therapy used in these patients, and the lipid goals reached in real life. Our aim was to evaluate the achievement of low-density lipoprotein cholesterol (LDL-C) treatment goals in FH patients younger than 18 years enrolled in a large national registry.

METHODS:

We analyzed patients younger than 18 years enrolled in a large ongoing registry of molecularly-defined patients with FH in Spain. The attainment of guideline-recommended plasma LDL-C goals at entry and follow-up was analyzed in relation to the use of lipid-lowering therapy.

RESULTS:

We enrolled 392 individuals younger than 18 years. Of these, 217 were molecularly-diagnosed FH patients and had a complete follow-up. The median follow-up time was 4.69 years (interquartile range, 2.48-6.38 years), 68.2% of FH patients were on statins, and 41.5% patients had LDL-C < 130mg/dL. Statin use was the only predictor of LDL-C goal attainment.

CONCLUSIONS:

This study shows that a high proportion of FH patients younger than 18 years have high LDL-C levels and fail to achieve recommended LDL-C targets. Statin use was the only independent predictor of LDL-C goal achievement. No safety concerns were detected during follow-up. These results indicate that many FH patients are not adequately controlled and that there is still room for treatment improvement.

KEYWORDS:

Adolescentes; Adolescents; Cardiovascular disease; Children; Enfermedad cardiovascular; Estatinas; Familial hypercholesterolemia; Hipercolesterolemia familiar; Lipid-lowering therapy; Low-density lipoprotein cholesterol goals; Niños; Objetivos de colesterol unido a lipoproteínas de baja densidad; Statins; Terapia hipolipemiante
PMID:
 
27913073
 
DOI:
 
10.1016/j.rec.2016.10.010
[PubMed - as supplied by publisher]

No hay comentarios:

Publicar un comentario